Business

P&G Hygiene & Health Posts Twofold Surge in Q1 Profit to INR 192 Cr; Revenue Touches INR 937 Cr

Despite the muted topline growth, the surge in profit was attributed to a favourable comparison with a high advertising spend base in the corresponding quarter of the previous fiscal, the company said in its earnings release.

• By PTI
• New Delhi
• Jul 31, 2025

Business

Procter & Gamble Hygiene and Health Care Ltd (PGHH) reported a sharp upswing in profitability for the quarter ended June 2025, with its profit after tax (PAT) more than doubling year-on-year to ₹192.06 crore. The company had posted a PAT of ₹81.06 crore during the same quarter last year.

PGHH’s revenue from operations edged up slightly to ₹937.03 crore, registering a modest 0.56% growth compared to ₹931.75 crore in the year-ago period. Despite the muted topline growth, the surge in profit was attributed to a favourable comparison with a high advertising spend base in the corresponding quarter of the previous fiscal, the company said in its earnings release.

A significant reduction in expenses also contributed to the improved bottom line. Total expenses for the quarter declined by 17.75% to ₹680.02 crore, further boosting profitability.

The company, which markets leading healthcare and feminine hygiene brands such as Vicks and Whisper, saw its total income—factoring in other income—rise marginally to ₹944.72 crore.

Earlier this year, PGHH’s board approved a shift in its financial year cycle from July–June to April–March, aligning it with the conventional fiscal calendar. Consequently, the financial year 2024–25 spanned a nine-month period from July 1, 2024, to March 31, 2025.

Shares of PGHH responded positively to the earnings report, closing at ₹13,885 on the BSE—up 6.12% from the previous session’s close.

The performance highlights PGHH’s ability to deliver strong earnings even amid moderate revenue growth, driven by disciplined cost management and strategic investment cycles.